5FI7
Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]oxy]pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]ethanamide
Functional Information from GO Data
Chain | GOid | namespace | contents |
A | 0004359 | molecular_function | glutaminase activity |
A | 0006541 | biological_process | glutamine metabolic process |
B | 0004359 | molecular_function | glutaminase activity |
B | 0006541 | biological_process | glutamine metabolic process |
C | 0004359 | molecular_function | glutaminase activity |
C | 0006541 | biological_process | glutamine metabolic process |
D | 0004359 | molecular_function | glutaminase activity |
D | 0006541 | biological_process | glutamine metabolic process |
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 15 |
Details | binding site for residue 5XZ A 601 |
Chain | Residue |
A | LYS319 |
D | PHE321 |
D | LEU322 |
D | ASN323 |
D | ASP326 |
D | TYR393 |
D | LYS397 |
A | LEU320 |
A | PHE321 |
A | LEU322 |
A | ASN323 |
A | GLU324 |
A | TYR393 |
D | LYS319 |
D | LEU320 |
site_id | AC2 |
Number of Residues | 14 |
Details | binding site for residue 5XZ C 601 |
Chain | Residue |
B | LYS319 |
B | LEU320 |
B | PHE321 |
B | LEU322 |
B | TYR393 |
C | LYS319 |
C | LEU320 |
C | PHE321 |
C | LEU322 |
C | ASN323 |
C | GLU324 |
C | ASP326 |
C | TYR393 |
C | LYS397 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 24 |
Details | BINDING: BINDING => ECO:0000269|PubMed:22049910, ECO:0000269|PubMed:22538822, ECO:0000305|PubMed:24451979, ECO:0007744|PDB:3CZD, ECO:0007744|PDB:3UNW, ECO:0007744|PDB:3VP0, ECO:0007744|PDB:3VP1 |
Chain | Residue | Details |
A | SER285 | |
B | TYR413 | |
B | TYR465 | |
B | VAL483 | |
C | SER285 | |
C | ASN334 | |
C | GLU380 | |
C | TYR413 | |
C | TYR465 | |
C | VAL483 | |
D | SER285 | |
A | ASN334 | |
D | ASN334 | |
D | GLU380 | |
D | TYR413 | |
D | TYR465 | |
D | VAL483 | |
A | GLU380 | |
A | TYR413 | |
A | TYR465 | |
A | VAL483 | |
B | SER285 | |
B | ASN334 | |
B | GLU380 |
site_id | SWS_FT_FI2 |
Number of Residues | 4 |
Details | BINDING: BINDING => ECO:0000269|PubMed:22049910, ECO:0000269|PubMed:22538822, ECO:0000305|PubMed:24451979, ECO:0007744|PDB:3CZD, ECO:0007744|PDB:3UNW, ECO:0007744|PDB:3VP1 |
Chain | Residue | Details |
A | ASN387 | |
B | ASN387 | |
C | ASN387 | |
D | ASN387 |
site_id | SWS_FT_FI3 |
Number of Residues | 4 |
Details | SITE: Cleavage; by MPP => ECO:0000250|UniProtKB:P13264 |
Chain | Residue | Details |
A | LEU71 | |
B | LEU71 | |
C | LEU71 | |
D | LEU71 |
site_id | SWS_FT_FI4 |
Number of Residues | 8 |
Details | MOD_RES: N6-succinyllysine => ECO:0000250|UniProtKB:D3Z7P3 |
Chain | Residue | Details |
A | LYS129 | |
A | LYS163 | |
B | LYS129 | |
B | LYS163 | |
C | LYS129 | |
C | LYS163 | |
D | LYS129 | |
D | LYS163 |
site_id | SWS_FT_FI5 |
Number of Residues | 4 |
Details | MOD_RES: N6-acetyllysine => ECO:0007744|PubMed:19608861 |
Chain | Residue | Details |
A | LYS310 | |
B | LYS310 | |
C | LYS310 | |
D | LYS310 |